Landscape and progress of global COVID-19 vaccine development. Issue 10 (3rd October 2021)

• Record Type: Journal Article
• Authors: Huang, Hui-Yao; Wang, Shu-Hang; Tang, Yu; Sheng, Wei; Zuo, Chi-Jian; Wu, Da-Wei; Fang, Hong; Du, Qiong; Li, Ning
• Is Part Of: Human vaccines & immunotherapeutics. Volume 17:Issue 10(2021)
• Page Start: 3276
• Page End: 3280
• Publication Date: 2021-10-03
• Subjects: Clinical trial -- COVID-19 -- vaccine -- lanscape; Vaccines -- Periodicals; 615.372
• DOI: 10.1080/21645515.2021.1945901
• Languages: English
• ISSNs: 2164-5515

Abstract

ABSTRACT: The emergence of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has affected billions of lives globally, and the world hopes to end this epidemic by effective vaccination. In this review, we depict the latest panorama of global COVID-19 vaccine research and development based on different technology platforms, and summarize key characteristics and available evidence on vaccines authorized for emergency use, in order to provide insights into improve coordination in the COVID-19 outbreak response for related stakeholders.